EHTH Quote, Financials, Valuation and Earnings

Goosehead Insurance has a net margin of 30.93% compared to eHealth's net margin of 15.82%. eHealth's return on equity of 1.6% beat Goosehead Insurance's return on equity of 228.38%.

eHealth has a consensus price target of $10.63, signalling upside risk potential of 59.06%. On the other hand Goosehead Insurance has an analysts' consensus of $118.50 which suggests that it could grow by 0.37%. Given that eHealth has higher upside potential than Goosehead Insurance, analysts believe eHealth is more attractive than Goosehead Insurance.

eHealth has a beta of 0.810, which suggesting that the stock is 19.024% less volatile than S&P 500. In comparison Goosehead Insurance has a beta of 1.476, suggesting its more volatile than the S&P 500 by 47.556%.

eHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Goosehead Insurance offers a yield of 0% to investors and pays a quarterly dividend of $5.91 per share. eHealth pays 55.3% of its earnings as a dividend. Goosehead Insurance pays out -- of its earnings as a dividend. eHealth's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

eHealth quarterly revenues are $315.2M, which are larger than Goosehead Insurance quarterly revenues of $93.9M. eHealth's net income of $97.5M is higher than Goosehead Insurance's net income of $14.9M. Notably, eHealth's price-to-earnings ratio is -- while Goosehead Insurance's PE ratio is 102.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for eHealth is 0.37x versus 14.38x for Goosehead Insurance. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 30.93% compared to eHealth's net margin of 12.92%. eHealth's return on equity of 1.6% beat Kingstone Companies's return on equity of 38.66%.

eHealth has a consensus price target of $10.63, signalling upside risk potential of 59.06%. On the other hand Kingstone Companies has an analysts' consensus of $19.00 which suggests that it could grow by 14.11%. Given that eHealth has higher upside potential than Kingstone Companies, analysts believe eHealth is more attractive than Kingstone Companies.

eHealth has a beta of 0.810, which suggesting that the stock is 19.024% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.481, suggesting its less volatile than the S&P 500 by 51.89%.

eHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. eHealth pays 55.3% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend. eHealth's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

eHealth quarterly revenues are $315.2M, which are larger than Kingstone Companies quarterly revenues of $42.1M. eHealth's net income of $97.5M is higher than Kingstone Companies's net income of $5.4M. Notably, eHealth's price-to-earnings ratio is -- while Kingstone Companies's PE ratio is 11.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for eHealth is 0.37x versus 1.33x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Companies has a net margin of 30.93% compared to eHealth's net margin of 12.99%. eHealth's return on equity of 1.6% beat Marsh & McLennan Companies's return on equity of 30.77%.

eHealth has a consensus price target of $10.63, signalling upside risk potential of 59.06%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $235.65 which suggests that it could fall by -3.43%. Given that eHealth has higher upside potential than Marsh & McLennan Companies, analysts believe eHealth is more attractive than Marsh & McLennan Companies.

eHealth has a beta of 0.810, which suggesting that the stock is 19.024% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.849, suggesting its less volatile than the S&P 500 by 15.053%.

eHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Marsh & McLennan Companies offers a yield of 1.29% to investors and pays a quarterly dividend of $0.82 per share. eHealth pays 55.3% of its earnings as a dividend. Marsh & McLennan Companies pays out 37.27% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

eHealth quarterly revenues are $315.2M, which are smaller than Marsh & McLennan Companies quarterly revenues of $6.1B. eHealth's net income of $97.5M is lower than Marsh & McLennan Companies's net income of $788M. Notably, eHealth's price-to-earnings ratio is -- while Marsh & McLennan Companies's PE ratio is 29.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for eHealth is 0.37x versus 4.95x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.

Reliance Global Group has a net margin of 30.93% compared to eHealth's net margin of -42.41%. eHealth's return on equity of 1.6% beat Reliance Global Group's return on equity of -254.59%.

eHealth has a consensus price target of $10.63, signalling upside risk potential of 59.06%. On the other hand Reliance Global Group has an analysts' consensus of -- which suggests that it could grow by 9900.01%. Given that Reliance Global Group has higher upside potential than eHealth, analysts believe Reliance Global Group is more attractive than eHealth.

eHealth has a beta of 0.810, which suggesting that the stock is 19.024% less volatile than S&P 500. In comparison Reliance Global Group has a beta of -0.309, suggesting its less volatile than the S&P 500 by 130.907%.

eHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Reliance Global Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. eHealth pays 55.3% of its earnings as a dividend. Reliance Global Group pays out -- of its earnings as a dividend. eHealth's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

eHealth quarterly revenues are $315.2M, which are larger than Reliance Global Group quarterly revenues of $3.3M. eHealth's net income of $97.5M is higher than Reliance Global Group's net income of -$1.4M. Notably, eHealth's price-to-earnings ratio is -- while Reliance Global Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for eHealth is 0.37x versus 0.09x for Reliance Global Group. Usually stocks with elevated PS ratios are considered overvalued.